Skip to main content
. 2019 Nov 14;10:2650. doi: 10.3389/fimmu.2019.02650

Figure 7.

Figure 7

IVX improved LPS-induced sickness behavior in mice. (A) Experimental design of a LPS-induced neuroinflammatory model. Mice were injected in the lateral ventricle with 5 μg STO-609 or 5 μg SR-18292 for 24 h, then treated with intraperitoneally injected IVX (10 mg/kg) daily for 3 consecutive days and then subcutaneously injected with LPS (0.33 mg/kg) for 24 h. (B,E) The changes in mouse body weight from before to after the experiment. (C,D,F,G) The locomotor activity of mice was measured via an open field test. Results are expressed as means ± SEM (n= 8–10, in each group). ##p < 0.01, vs. control group; **p< 0.01 vs. LPS group; $p < 0.05 and $$p < 0.01 vs. IVX + LPS group.